2-year Weight Loss Study for People With Obesity Without Diabetes

Written By Patrick Smith

Are you living with overweight or obesity and do not have diabetes? 

If so, you may be eligible to participate in a clinical research study evaluating an investigational GLP-1 medicine (LY900043) for weight management.

ABOUT THE STUDY

This is a Phase 2 study evaluatinghow LY900043 affects body weight.

WHO MAY QUALIFY? 

You may be eligible to participate if you meet all the following: 

  • Age 18 years or older

  • Body mass index (BMI) of 35 or higher (classified as obesity) 

  • Do not have diabetes

  • Have never taken any glucose-lowering medications

  • Have not used any GLP-1-based medication — including pills or injections (such as Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, or Foundayo) within the past 3 months

  • Have not used metformin within the past 3 months 

  • Have never had surgery for treatment of obesity

INTERESTED IN LEARNING MORE? 

Click below to complete a short questionnaire to see if you may be eligible.
(JotForm link) 

Study Sponsor: Eli Lilly and Company

ClinicalTrials.gov ID: NCTXXXXXXXX link

Patrick Smith
Previous

69-week Weight Loss Study for People With Overweight or Obesity Without Diabetes